Riskpilot← Back to searchSign inGet full accessSaLiMa Företagshälsoutveckling AB
ABActiveOrg 5567100846Tranbärsvägen 23 AOther human health activities n.e.c. · NACE 8699Est. 20061 employees
Revenue 2025
SEK 1,6M
+3% vs 2024
EBITDA margin
46.6%
+42% vs 2024
Equity ratio
66.0%
Financial strength
Net profit 2025
SEK 462K
+6% vs 2024
| Revenue | SEK 1,6M | +3% |
| EBITDA | SEK 765K | +42% |
| Net profit | SEK 462K | +6% |
| Total assets | SEK 3,4M | +18% |
| Equity | SEK 2,2M | +13% |
| Employees | 1 | — |
Legal name
SaLiMa Företagshälsoutveckling AB
Org number
5567100846
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
30 augusti 2006
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva företagshälsovård och hälsoutveckling samt därmed förenlig verksamhet.
Address
Tranbärsvägen 23 A
Email
lisa@salima.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 158 | 1 645 | 1 559 | 1 587 | 1 641 |
| Staff expenses | — | −594 | −407 | −532 | −513 |
| EBITDA | 333 | 527 | 574 | 540 | 765 |
| Depreciation & amort. | −42 | −54 | −56 | −56 | −62 |
| EBIT | 291 | 473 | 518 | 484 | 703 |
| Net financials | — | −0 | 16 | 99 | 52 |
| Profit before tax | 320 | 412 | 456 | 546 | 588 |
| Tax | −71 | −89 | −97 | −109 | −126 |
| Net profit | 249 | 323 | 359 | 436 | 462 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 870 | 2 135 | 2 388 | 2 843 | 3 362 |
| Equity | 987 | 1 310 | 1 519 | 1 956 | 2 218 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 447 | 328 | 294 | 276 | 365 |
| Total debt | 447 | 328 | 294 | 276 | 365 |
EBITDA margin
46.6%
This company
15.8%
Market median
+195% vs market
20212025
Equity ratio
66.0%
This company
38.2%
Market median
+73% vs market
20212025
Return on equity
20.8%
This company
18.4%
Market median
+13% vs market
20212025
Net profit margin
28.2%
This company
8.1%
Market median
+248% vs market
20212025
Asset turnover
0.49×
This company
1.12×
Market median
-56% vs market
20212025
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SaLiMa Företagshälsoutveckling AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lisbeth Mari-Ann Hjärne | Chairman | 0 companies |
| Mats Olov Nilsson | Deputy Board Member | 0 companies |
| Anna Maria Hjärne | Board of Directors | 0 companies |
| Sara Marianne Hjärne | Board of Directors | 0 companies |